Jeffrey Robert Ajer - Apr 30, 2021 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Commercial Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Apr 30, 2021
Transactions value $
-$180,247
Form type
4
Date filed
10/28/2021, 07:48 PM
Next filing
Sep 24, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $21.3K +342 +0.59% $62.41 58.6K Apr 30, 2021 Direct F1
transaction BMRN Common Stock Sale -$202K -2.74K -4.67% $73.60 55.9K Oct 26, 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired by the reporting person on April 30, 2021, pursuant to the issuer's Employee Stock Purchase Plan.
F2 Trade made pursuant to a 10b5-1 plan executed on December 3, 2020.